(4R)-4-hydroxy-4-[(3S)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one

Details

Top
Internal ID 28b75fea-3c74-4cb8-98e9-bce1260ca5d2
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (4R)-4-hydroxy-4-[(3S)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one
SMILES (Canonical) CC1=CC(=O)CC(C1(CCC(C)O)O)(C)C
SMILES (Isomeric) CC1=CC(=O)CC([C@@]1(CC[C@H](C)O)O)(C)C
InChI InChI=1S/C13H22O3/c1-9-7-11(15)8-12(3,4)13(9,16)6-5-10(2)14/h7,10,14,16H,5-6,8H2,1-4H3/t10-,13-/m0/s1
InChI Key CWOFGGNDZOPNFG-GWCFXTLKSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C13H22O3
Molecular Weight 226.31 g/mol
Exact Mass 226.15689456 g/mol
Topological Polar Surface Area (TPSA) 57.50 Ų
XlogP 0.80
Atomic LogP (AlogP) 1.82
H-Bond Acceptor 3
H-Bond Donor 2
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (4R)-4-hydroxy-4-[(3S)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-2-en-1-one

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9971 99.71%
Caco-2 + 0.8017 80.17%
Blood Brain Barrier + 0.6000 60.00%
Human oral bioavailability + 0.6000 60.00%
Subcellular localzation Mitochondria 0.8494 84.94%
OATP2B1 inhibitior - 0.8545 85.45%
OATP1B1 inhibitior + 0.9257 92.57%
OATP1B3 inhibitior + 0.9721 97.21%
MATE1 inhibitior - 0.9600 96.00%
OCT2 inhibitior - 0.5250 52.50%
BSEP inhibitior - 0.7448 74.48%
P-glycoprotein inhibitior - 0.9779 97.79%
P-glycoprotein substrate - 0.8606 86.06%
CYP3A4 substrate + 0.5215 52.15%
CYP2C9 substrate - 0.8060 80.60%
CYP2D6 substrate - 0.8744 87.44%
CYP3A4 inhibition - 0.7289 72.89%
CYP2C9 inhibition - 0.8817 88.17%
CYP2C19 inhibition - 0.9281 92.81%
CYP2D6 inhibition - 0.9340 93.40%
CYP1A2 inhibition - 0.9405 94.05%
CYP2C8 inhibition - 0.9922 99.22%
CYP inhibitory promiscuity - 0.8906 89.06%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8728 87.28%
Carcinogenicity (trinary) Non-required 0.6272 62.72%
Eye corrosion - 0.9868 98.68%
Eye irritation - 0.5526 55.26%
Skin irritation + 0.4900 49.00%
Skin corrosion - 0.9837 98.37%
Ames mutagenesis - 0.8500 85.00%
Human Ether-a-go-go-Related Gene inhibition - 0.8316 83.16%
Micronuclear - 0.9600 96.00%
Hepatotoxicity + 0.5302 53.02%
skin sensitisation + 0.7857 78.57%
Respiratory toxicity + 0.6667 66.67%
Reproductive toxicity + 0.6444 64.44%
Mitochondrial toxicity - 0.5000 50.00%
Nephrotoxicity - 0.5787 57.87%
Acute Oral Toxicity (c) III 0.6476 64.76%
Estrogen receptor binding - 0.9271 92.71%
Androgen receptor binding - 0.5937 59.37%
Thyroid receptor binding - 0.7069 70.69%
Glucocorticoid receptor binding - 0.5689 56.89%
Aromatase binding - 0.8415 84.15%
PPAR gamma - 0.8438 84.38%
Honey bee toxicity - 0.9470 94.70%
Biodegradation - 0.5000 50.00%
Crustacea aquatic toxicity - 0.7300 73.00%
Fish aquatic toxicity + 0.9797 97.97%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 97.22% 98.95%
CHEMBL253 P34972 Cannabinoid CB2 receptor 95.97% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.72% 96.09%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 91.22% 85.14%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 91.05% 95.56%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.63% 91.11%
CHEMBL4803 P29474 Nitric-oxide synthase, endothelial 83.98% 86.00%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 83.64% 94.45%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 82.61% 90.71%
CHEMBL4208 P20618 Proteasome component C5 81.64% 90.00%

Cross-Links

Top
PubChem 25755221
NPASS NPC81870
LOTUS LTS0269458
wikiData Q104400537